Cryptococcal Antigen Lateral Flow Assay (CrAg LFA), Reference # CR2003

FDA Device Recall #Z-1109-2017 - Class II, December 27, 2016

Recall Summary

Recall Number Z-1109-2017
Classification Class II - Moderate risk
Date Initiated December 27, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Immuno-Mycologics, Inc
Location Norman, OK
Product Type Devices
Quantity 630 units

Product Description

Cryptococcal Antigen Lateral Flow Assay (CrAg LFA), Reference # CR2003

Reason for Recall

The affected products have approximately a 91% specificity while the non-affected lots have approximately a 99% specificity. The recalling firm is aware of three customers who reported false positive results.

Distribution Pattern

Nationwide throughout the US

Lot / Code Information

161028133653JH, 161003111544KH, and 161007105036JG

Other Recalls from Immuno-Mycologics, Inc

Recall # Classification Product Date
Z-1984-2026 Class II Immy, Myco DDR Trident, Bulk Neutralization Buf... Mar 26, 2026
Z-1389-2025 Class II Candida ID Antigen, REAG, AG, REF C50110, Vol 1... Feb 10, 2025
Z-0545-2022 Class II CRYPTOCOCCAL ANTIGEN LATERAL FLOW ASSAY, IMMY, ... Jan 3, 2022
Z-2301-2020 Class II Histoplasma Immunodiffusion (ID) Antigen; The I... Nov 4, 2019
Z-2409-2018 Class II Cryptococcal Antigen Lateral Flow Assay (CrAg L... Mar 30, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.